Niki BioSolutions, Inc. Financial Ratios — NIKI Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-80.36	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-38.71	-54.14	20.73	-75.75	-45.82	-13.61	-23.21	-7.83
Return on Capital (%)	- -	- -	- -	-1,867.98	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	-65.23	- -	- -	- -	- -	- -
Gross Margin (%)	- -	17.07	-48.47	-11.36	5.31	6.18	2.45	- -	- -
EBITDA Margin (%)	- -	-2,515.53	-3,157.68	-2,077.97	-1,168.45	-1,205.12	-2,138.18	- -	- -
Operating Margin (%)	- -	-2,693.47	-3,400.52	-2,224.39	-1,245.8	-1,325.24	-2,457.53	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,761.55	- -
Pretax Margin (%)	- -	-3,946.93	-3,759.01	539.78	-1,758.64	-889.36	-1,006.3	- -	- -
Profit Margin (%)	- -	-3,867.97	-3,491.77	775.29	-1,624.64	-756.2	-654.8	- -	- -
Net Income to Common Margin (%)	- -	-3,867.97	-3,491.77	775.29	-1,624.64	-756.2	-654.8	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-80.36	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	10	6	3	- -	7	3	3	3
ST Debt	- -	10	- -	- -	- -	6	- -	3	3
LT Debt	- -	- -	6	2	- -	1	3	- -	- -
Total Debt/EBITDA	- -	-1.07	-0.38	-0.14	-0.01	-0.44	-0.36	-1.24	-1.89
Net Debt/EBITDA	- -	0.2	-0.07	0.08	0.45	-0.3	-0.11	-0.88	0.02
Total Debt/EBIT	- -	-1	-0.36	-0.13	-0.01	-0.4	-0.31	-1.12	-1.89
Net Debt/EBIT	- -	0.18	-0.06	0.07	0.42	-0.27	-0.1	-0.79	0.02
EBITDA to Interest Expense	- -	-2.16	-4.57	-77.75	-192.46	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-3.52	-4.87	-78.41	-193.94	- -	- -	- -	- -
EBIT to Interest Expense	- -	-2.32	-4.92	-83.22	-205.21	- -	- -	- -	- -
Interest Expense	- -	4	4	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	80.22	25.73	-35.57	7.99	-90.83	-141.99	-330.24	-449.03	-394.8
Long-Term Debt/Equity (%)	- -	0.44	43.28	5.79	0.14	6.78	20.53	0.12	- -
Long-Term Debt/Capital (%)	- -	0.67	-180.76	86.9	-0.09	-1.73	-4.25	-0.02	- -
Long-Term Debt/Total Assets (%)	- -	0.32	26.83	5	0.11	2.54	15.3	0.09	- -
Total Debt/Equity (%)	1.59	31.44	43.59	7.06	1.24	87.51	21.34	28.49	24.96
Total Debt/Capital (%)	1.86	47.83	-182.07	105.85	-0.84	-22.36	-4.42	-4.28	-4.32
Total Debt/Total Assets (%)	1.52	22.84	27.03	6.09	0.99	32.85	15.91	20.8	18.42
Net Debt to Equity	-52.15	-5.8	7.69	-3.9	-46.45	59.12	6.85	20.08	-0.25
Net Debt/Capital (%)	-165.32	-19.96	-13.05	156.33	23.98	-14.23	-1.38	-2.98	0.04
EBITDA	- -	-10	-17	-19	-18	-16	-9	-3	-2
EBITDA-CapEx	- -	-16	-18	-19	-18	-16	-9	-3	-2
Operating Income (Loss)	- -	-10	-18	-20	-19	-17	-11	-3	-2

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	13.69	1.07	2.34	8.24	1.91	0.16	0.96	0.2	0.75
Current Ratio	15.24	2.36	3	8.7	2.9	0.57	1.18	0.22	0.78
Quick Ratio	13.85	1.16	2.52	8.33	2.74	0.27	0.99	0.2	0.75
CFO/Avg Current Liab	- -	-1.49	-1.8	-4.87	-3.55	-1.46	-1.06	-0.37	-0.41
Common Equity/Total Assets	80.22	25.73	-35.57	7.99	-90.83	-141.99	-330.24	-449.03	-394.8
Long-Term Debt/Equity (%)	- -	0.44	43.28	5.79	0.14	6.78	20.53	0.12	- -
Long-Term Debt/Capital (%)	- -	0.67	-180.76	86.9	-0.09	-1.73	-4.25	-0.02	- -
Long-Term Debt/Total Assets (%)	- -	0.32	26.83	5	0.11	2.54	15.3	0.09	- -
Total Debt/Equity (%)	1.59	31.44	43.59	7.06	1.24	87.51	21.34	28.49	24.96
Total Debt/Capital (%)	1.86	47.83	-182.07	105.85	-0.84	-22.36	-4.42	-4.28	-4.32
Total Debt/Total Assets (%)	1.52	22.84	27.03	6.09	0.99	32.85	15.91	20.8	18.42
CFO/Total Liabilities	- -	-81.4	-147.02	-262.08	-332.91	-94.51	-146.94	-27.33	-37.48
CFO/CapEx	- -	-1.65	-12.09	-98.76	-106.34	-65.91	-2,561.98	- -	- -
Altman's Z-Score	0.64	-0.87	-4.67	-1.69	-6.16	-7.62	-6.32	-7.15	-5.91

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	271.28	24.68	17.74	21.88	10.24	3.88	- -	- -
Days Sales Outstanding	- -	1.35	14.79	20.58	16.68	35.65	93.98	- -	- -
Inventory Turnover	- -	20.76	24.51	27.69	38.98	38.3	30.36	- -	- -
Days Inventory Outstanding	- -	17.58	14.89	13.18	9.36	9.53	12.02	- -	- -
Accounts Payable Turnover	- -	17.37	39.77	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	21.01	9.18	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	-2.08	20.5	33.76	26.05	45.18	106	- -	- -
Inventory to Cash Days	- -	-16.24	-0.1	7.39	7.32	26.12	81.95	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	16	12	5	3	8	2	2	1	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	-2	-4	-6	-8	-9	-9	-9
+ Total Debt	- -	10	6	3	- -	7	3	3	3
Enterprise Value	-18	-3	-1	-33	-14	-3	-8	-7	-9
Total Capital	26	22	-4	3	-26	-31	-74	-78	-80
Total Debt/Capital (%)	1.86	47.83	-182.07	105.85	-0.84	-22.36	-4.42	-4.28	-4.32
Total Debt / EV	-0.03	-3.33	-5.03	-0.08	-0.02	-2.28	-0.4	-0.49	-0.37
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-16	-2	- -	-4	-14	-3	-8	-7	-9
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	1	1	2	1	- -	- -	- -
TTM EBITDA	- -	-10	-17	-19	-18	-16	-9	-3	-2
TTM Operating Income	- -	-10	-18	-20	-19	-17	-11	-3	-2
TTM Cash Flow to Firm	- -	-6	-10	-16	-15	-12	-8	-1	-2
TTM Free Cash Flow to Firm	- -	- -	-9	-16	-14	-12	-8	-1	-2

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-18	-3	-1	-33	-14	-3	-8	-7	-9
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	0.22	0.01	0.24	0.78	0.19	0.89	2.55	5.16
EV/EBITDA High	- -	0.22	0.01	0.24	0.78	0.19	0.89	2.55	5.16
EV/EBITDA Low	- -	0.22	0.01	0.24	0.78	0.19	0.89	2.55	5.16
EV/EBIT Average	- -	0.2	0.01	0.22	0.73	0.17	0.77	2.29	5.16
EV/EBIT High	- -	0.2	0.01	0.22	0.73	0.17	0.77	2.29	5.16
EV/EBIT Low	- -	0.2	0.01	0.22	0.73	0.17	0.77	2.29	5.16
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Average	-16	-2	- -	-4	-14	-3	-8	-7	-9
Enterprise Value High	-16	-2	- -	-4	-14	-3	-8	-7	-9
Enterprise Value Low	-16	-2	- -	-4	-14	-3	-8	-7	-9

Shares Outstanding	2	3	3	3	4	4	5	6	8
Diluted Weighted Avg Shares	- -	3	3	3	4	4	5	- -	- -
Basic Weighted Avg Shares	- -	3	3	3	4	4	5	- -	- -
Revenue per Share	- -	0.14	0.18	0.29	0.44	0.36	0.1	- -	- -
EBITDA per Share	- -	-3.46	-5.83	-6.08	-5.14	-4.38	-2.04	- -	- -
Operating Income per Share	- -	-3.7	-6.27	-6.51	-5.48	-4.81	-2.34	- -	- -
Basic EPS, GAAP	- -	-5.31	-6.44	2.27	-7.15	-2.75	-0.62	- -	- -
Basic EPS from Cont Ops	- -	-5.42	-6.93	1.58	-7.74	-3.23	-0.96	- -	- -
Diluted EPS, GAAP	- -	-5.31	-6.44	2.24	-7.15	-2.75	-0.62	- -	- -
Diluted EPS from Cont Ops	- -	-5.42	-6.93	1.56	-7.74	-3.23	-0.96	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-3.6	-4.61	-5.12	-4.18	-3.45	-1.71	- -	- -
Free Cash Flow per Basic Share	- -	-5.77	-5	-5.17	-4.22	-3.5	-1.71	- -	- -
Cash & Equivalents per Share	- -	4.67	2.16	10.24	2.39	0.56	0.44	- -	- -
Book Value per Share	- -	4.15	-2.94	1.13	-5.68	-8.3	-15.08	- -	- -
Tangible Book Value per Share	- -	11.23	4.67	11.94	4.75	1.98	3.37	- -	- -

Niki BioSolutions, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)